TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES Stock

Certificat

DE000CU7BUM7

Real-time Boerse Frankfurt Warrants 12:56:38 2024-05-03 pm EDT
8.31 EUR -0.12% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES
Current month-0.48%
1 month+2.34%
Date Price Change Volume
24-05-03 8.31 -0.12% 0
24-05-02 8.32 -0.48% 0
24-04-30 8.36 -0.83% 0
24-04-29 8.43 +3.31% 0
24-04-26 8.16 +7.79% 0

Real-time Boerse Frankfurt Warrants

Last update May 03, 2024 at 12:56 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Société Générale Société Générale
WKN CU7BUM
ISINDE000CU7BUM7
Date issued 2019-08-08
Strike 5.206 $
Maturity Unlimited
Parity 1 : 1
Emission price 3.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.95
Lowest since issue 2.21
Spread 0.01
Spread %0.12%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
14.08 USD
Average target price
15.74 USD
Spread / Average Target
+11.76%
Consensus